ResMed Inc. (RMD)
Healthcare · Medical - Instruments & Supplies · Data as of 2026-09-01
Bottom line
RMD is trading at a discount to its history, near its historical support zone, and recent volume suggests money flowing in. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
RMD trades at 23× earnings, below its own 5-year average of 31× and below similar healthcare companies we track (29×, 52 peers). Historically this has been on the cheaper side for the stock. It also generates strong cash: a free-cash-flow yield of about 8%. Its current multiple sits around the 11th percentile of its own last five years — toward the low end of its own range. Its fundamentals scored 7 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — Near its historical support zone (Green)
At $231.36, the stock is close to the lower end of its recent range. Over the past year RMD has traded between $180.27 and $284.87; its historical support zone sits near $228.65 and resistance near $284.87. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $180.27–$284.87 · 50-day average $213.24 · 200-day average $228.65
Money flow — Money is flowing in (Green)
Recent trading in RMD shows more volume on rising days than falling days, a pattern often described as accumulation. Volume on up days has been about 1.4× volume on down days over the last 30 sessions.
About the company
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
一句话结论
RMD 相对自身历史处于折价水平，接近其历史支撑区，近期成交量显示资金正在流入。从历史来看，这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
RMD 目前的市盈率为 23×，低于其自身 5 年平均的 31×，并且低于我们追踪的同类Healthcare公司（29×，52 家）。从历史来看，这属于该股较便宜的一侧。它同时产生充沛的现金：自由现金流收益率约为 8%。它当前的估值倍数大约位于自身过去五年分布的第 11 百分位——处于自身区间的偏低位置。在一套标准的逐年基本面核对清单上，它 9 项中通过了 7 项——上一财年多数底层趋势在改善。
价格区间 — 接近其历史支撑区
目前价格为 $231.36，接近其近期区间的下沿。过去一年 RMD 的价格在 $180.27 到 $284.87 之间波动；其历史支撑区在 $228.65 附近，阻力区在 $284.87 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 资金正在流入
RMD 近期上涨日的成交量高于下跌日，这种形态常被称为吸筹。过去 30 个交易日，上涨日的成交量约为下跌日的 1.4×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.